[Federal Register Volume 77, Number 81 (Thursday, April 26, 2012)]
[Notices]
[Pages 24970-24971]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-10140]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Fast Fail--Experimental Medicines Contracts--Mood 
and Anxiety Disorders.
    Date: May 22, 2012.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: David I. Sommers, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, National Institutes of Health, 6001 Executive Blvd., 
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861, 
[email protected].

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Fast Fail--Experimental Medicines Contracts--Autism.
    Date: May 24, 2012.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: David I. Sommers, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, National Institutes of Health, 6001 Executive Blvd., 
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861, 
[email protected].

    Name of Committee: National Institute of Mental Health Special 
Emphasis Panel; Fast Fail--Experimental Medicines Contracts--
Psychotic Spectrum.
    Date: May 25, 2012.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive

[[Page 24971]]

Boulevard, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: David I. Sommers, Ph.D., Scientific Review 
Officer, Division of Extramural Activities, National Institute of 
Mental Health, National Institutes of Health, 6001 Executive Blvd., 
Room 6154, MSC 9606, Bethesda, MD 20892-9606, 301-443-7861, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.242, 
Mental Health Research Grants; 93.281, Scientist Development Award, 
Scientist Development Award for Clinicians, and Research Scientist 
Award; 93.282, Mental Health National Research Service Awards for 
Research Training, National Institutes of Health, HHS)

    Dated: April 18, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-10140 Filed 4-25-12; 8:45 am]
BILLING CODE 4140-01-P